INS and metabolic syndrome: In the past, Reaven introduced the concept of 'syndrome X,' later renamed metabolic syndrome (MetS), suggesting its central role in the development of atherosclerotic cardiovascular diseases (ASCVDs) and type 2 diabetes mellitus (DMT2), primarily due to resistance to insulin action in target tissues.